Defining GM-CSF- and Macrophage-CSF-Dependent Macrophage Responses by In Vitro Models, The Journal of Immunology, vol.188, issue.11, pp.5752-65, 2012. ,
DOI : 10.4049/jimmunol.1103426
Macrophage plasticity and polarization: in vivo veritas, Journal of Clinical Investigation, vol.122, issue.3, pp.787-95, 2012. ,
DOI : 10.1172/JCI59643DS1
Interferon-?? reverses the immunosuppressive and protumoral properties and prevents the generation of human tumor-associated macrophages, International Journal of Cancer, vol.21, issue.2, pp.367-73, 2009. ,
DOI : 10.1002/ijc.24401
IL-34 induces the differentiation of human monocytes into immunosuppressive macrophages. antagonistic effects of GM-CSF and IFNgamma, PLoS One, vol.823409120, p.56045, 2013. ,
Immunosuppressive networks in the tumour environment and their therapeutic relevance, Nature Reviews Cancer, vol.1, issue.4, pp.263-74, 2005. ,
DOI : 10.1073/pnas.96.26.15074
Macrophage polarization in tumour progression, Seminars in Cancer Biology, vol.18, issue.5, pp.349-55, 2008. ,
DOI : 10.1016/j.semcancer.2008.03.004
Tumour-associated macrophages as a prototypic type II polarised phagocyte population: role in tumour progression, European Journal of Cancer, vol.40, issue.11, pp.1660-1667, 2004. ,
DOI : 10.1016/j.ejca.2004.03.016
Deciphering and Reversing Tumor Immune Suppression, Immunity, vol.39, issue.1, pp.61-73, 2013. ,
DOI : 10.1016/j.immuni.2013.07.005
Tumor-associated leukemia inhibitory factor and IL-6 skew monocyte differentiation into tumor-associated macrophage-like cells, Blood, vol.110, issue.13, pp.4319-4349, 2007. ,
DOI : 10.1182/blood-2007-02-072587
Control of granulocytes and macrophages: molecular, cellular, and clinical aspects, Science, vol.254, issue.5031, pp.529-562, 1991. ,
DOI : 10.1126/science.1948028
Anticancer Chemotherapy-Induced Intratumoral Recruitment and Differentiation of Antigen-Presenting Cells, Immunity, vol.38, issue.4, pp.729-770, 2013. ,
DOI : 10.1016/j.immuni.2013.03.003
ATPdependent recruitment, survival and differentiation of dendritic cell precursors in the tumor bed after anticancer chemotherapy, Onco Immunol, vol.2, 2013. ,
Nucleotide signalling during inflammation, Nature, vol.186, issue.7500, pp.310-317, 2014. ,
DOI : 10.1038/nature13085
Differential requirement for the activation of the inflammasome for processing and release of IL-1?? in monocytes and macrophages, Blood, vol.113, issue.10, pp.2324-2359, 2009. ,
DOI : 10.1182/blood-2008-03-146720
ATP is released by monocytes stimulated with pathogen-sensing receptor ligands and induces IL-1?? and IL-18 secretion in an autocrine way, Proceedings of the National Academy of Sciences, vol.105, issue.23, pp.8067-720709684105, 2008. ,
DOI : 10.1073/pnas.0709684105
Molecular Mechanisms of Purine and Pyrimidine Nucleotide Release, Adv Pharmacol, vol.61, pp.221-61, 2011. ,
DOI : 10.1016/B978-0-12-385526-8.00008-4
Nucleotides released by apoptotic cells act as a find-me signal to promote phagocytic clearance, Nature, vol.127, issue.7261, pp.282-165, 2009. ,
DOI : 10.1038/nature08296
Tumor Cell Death and ATP Release Prime Dendritic Cells and Efficient Anticancer Immunity, Cancer Research, vol.70, issue.3, pp.855-863, 2010. ,
DOI : 10.1158/0008-5472.CAN-09-3566
A2A adenosine receptor protects tumors from antitumor T cells, Proceedings of the National Academy of Sciences, vol.103, issue.35, pp.13132-13139, 2006. ,
DOI : 10.1073/pnas.0605251103
Role of G-protein-coupled adenosine receptors in downregulation of inflammation and protection from tissue damage, Nature, vol.120, issue.6866, pp.916-936, 2001. ,
DOI : 10.1038/414916a
Adenosine inhibits IL-12 and TNF-alpha production via adenosine A2a receptor-dependent and independent mechanisms, The FASEB Journal, vol.14, issue.13, pp.2065-7499, 2000. ,
DOI : 10.1096/fj.99-0508com
Adenosine receptor agonists differentially regulate IL-10, TNF-a and nitric oxide production in RAW 264.7 macrophages and in endotoxemic mice, J Immunol, vol.157, pp.4634-408906843, 1996. ,
Coordinated Adenine Nucleotide Phosphohydrolysis and Nucleoside Signaling in Posthypoxic Endothelium, The Journal of Experimental Medicine, vol.271, issue.5, pp.783-96, 2003. ,
DOI : 10.1515/BC.2003.054
Regulation of Macrophage Function by Adenosine, Arteriosclerosis, Thrombosis, and Vascular Biology, vol.32, issue.4, pp.865-874, 2012. ,
DOI : 10.1161/ATVBAHA.111.226852
Adenosine: an endogenous regulator of innate immunity, Trends in Immunology, vol.25, issue.1, pp.33-42, 2004. ,
DOI : 10.1016/j.it.2003.11.003
Adenosine receptors: therapeutic aspects for inflammatory and immune diseases, Nat Rev Drug Discov, vol.7, pp.759-70, 2008. ,
DOI : 10.1201/9781420005776
CD39 and CD73 in immunity and inflammation, Trends in Molecular Medicine, vol.19, issue.6, pp.355-67, 2013. ,
DOI : 10.1016/j.molmed.2013.03.005
Ecto-enzyme and signaling functions of lymphocyte CD 7 3, Immunological Reviews, vol.149, issue.1, pp.95-109, 1998. ,
DOI : 10.1083/jcb.115.1.75
Extracellular adenosine triphosphate and adenosine in cancer, Oncogene, vol.283, issue.39, pp.5346-58, 2010. ,
DOI : 10.1038/onc.2010.292
Activation of A2A Adenosine Receptor Attenuates Intestinal Inflammation in Animal Models of Inflammatory Bowel Disease, Gastroenterology, vol.129, issue.1, pp.26-33, 2005. ,
DOI : 10.1053/j.gastro.2005.05.032
Selective A2A adenosine agonist ATL-146e attenuates acute lethal liver injury in mice, Journal of Gastroenterology, vol.40, issue.5, pp.526-535, 2005. ,
DOI : 10.1007/s00535-005-1609-9
Role of A2a extracellular adenosine receptor-mediated signaling in adenosine-mediated inhibition of T-cell activation and expansion, Blood, vol.90, pp.1600-109269779, 1997. ,
Myeloid Expression of Adenosine A2A Receptor Suppresses T and NK Cell Responses in the Solid Tumor Microenvironment, Cancer Research, vol.74, issue.24, pp.7250-7259, 2014. ,
DOI : 10.1158/0008-5472.CAN-13-3583
Hypoxia-adenosinergic immunosuppression: tumor protection by T regulatory cells and cancerous tissue hypoxia Oct 1:5947; PMID:18829471, Clin Cancer Res, vol.http, 2008. ,
Anti-CD73 antibody therapy inhibits breast tumor growth and metastasis, Proceedings of the National Academy of Sciences, vol.107, issue.4, pp.1547-52, 2010. ,
DOI : 10.1073/pnas.0908801107
ENTPD1/CD39 is a promising therapeutic target in oncology, Oncogene, vol.22, issue.14, pp.1743-51, 2013. ,
DOI : 10.1038/onc.2012.269
Anti-CD39 and anti-CD73 antibodies A1 and 7G2 improve targeted therapy in ovarian cancer by blocking adenosine-dependent immune evasion, Am J Transl Res, vol.6, pp.129-3924489992, 2014. ,
Targeting Cancer-Derived Adenosine:New Therapeutic Approaches, Cancer Discovery, vol.4, issue.8, p.879, 2014. ,
DOI : 10.1158/2159-8290.CD-14-0341
Adenosine Receptor 2A Blockade Increases the Efficacy of Anti-PD-1 through Enhanced Antitumor T-cell Responses, Cancer Immunology Research, vol.3, issue.5, p.506, 2015. ,
DOI : 10.1158/2326-6066.CIR-14-0211
Targeting CD73 Enhances the Antitumor Activity of Anti-PD-1 and Anti-CTLA-4 mAbs, Clinical Cancer Research, vol.19, issue.20, p.5626, 2013. ,
DOI : 10.1158/1078-0432.CCR-13-0545
Inhibition of CD39 Enzymatic Function at the Surface of Tumor Cells Alleviates Their Immunosuppressive Activity, Cancer Immunology Research, vol.3, issue.3, pp.254-65, 2015. ,
DOI : 10.1158/2326-6066.CIR-14-0018
High expression of CD39/ENTPD1 in malignant epithelial cells of human rectal adenocarcinoma, Tumor Biology, vol.8, issue.12, pp.9411-9420, 2015. ,
DOI : 10.1007/s13277-015-3683-9
CD39/ENTPD1 Expression by CD4+Foxp3+ Regulatory T Cells Promotes Hepatic Metastatic Tumor Growth in Mice, Gastroenterology, vol.139, issue.3, pp.1030-1070, 2010. ,
DOI : 10.1053/j.gastro.2010.05.007
Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression, The Journal of Experimental Medicine, vol.261, issue.6, pp.1257-65, 2007. ,
DOI : 10.1074/jbc.275.3.2057
Differential Macrophage Activation Alters the Expression Profile of NTPDase and Ecto-5???-Nucleotidase, PLoS ONE, vol.265, issue.2, 2012. ,
DOI : 10.1371/journal.pone.0031205.s001
Human ectonucleotidase-expressing CD25high Th17 cells accumulate in breast cancer tumors and exert immunosuppressive functions, Onco Immunol, vol.5, 2016. ,
URL : https://hal.archives-ouvertes.fr/hal-01438254
Gout-associated uric acid crystals activate the NALP3 inflammasome, Nature, vol.20, issue.7081, pp.237-278, 2006. ,
DOI : 10.1038/nature04516
IL-34-and M-CSF-induced macrophages switch memory T cells into Th17 cells via membrane IL-1alpha ,
Shaping of monocyte and macrophage function by adenosine receptors, Pharmacology & Therapeutics, vol.113, issue.2, pp.264-75, 2007. ,
DOI : 10.1016/j.pharmthera.2006.08.003
IL-27 acts on DCs to suppress the T cell response and autoimmunity by inducing expression of the immunoregulatory molecule CD39, Nature Immunology, vol.2010, issue.10 ,
DOI : 10.1053/j.gastro.2010.05.007
Apoptotic tumor cells induce IL-27 release from human DCs to activate Treg cells that express CD69 and attenuate cytotoxicity, European Journal of Immunology, vol.14, issue.6, pp.1585-98, 2012. ,
DOI : 10.1002/eji.201142093
TLR stimulation initiates a CD39-based autoregulatory mechanism that limits macrophage inflammatory responses, Blood, vol.122, issue.11, pp.1935-1980, 2013. ,
DOI : 10.1182/blood-2013-04-496216
Extracellular Adenosine Triphosphate Affects the Response of Human Macrophages Infected With Mycobacterium tuberculosis, Journal of Infectious Diseases, vol.210, issue.5, pp.824-857, 2014. ,
DOI : 10.1093/infdis/jiu135
Immunological and Inflammatory Functions of the Interleukin-1 Family, Annual Review of Immunology, vol.27, issue.1, pp.519-50, 2009. ,
DOI : 10.1146/annurev.immunol.021908.132612
ATP release and purinergic signaling: a common pathway for particle-mediated inflammasome activation, Cell Death and Disease, vol.176, issue.10, 2012. ,
DOI : 10.1164/rccm.200808-1274OC
NTPDase1 governs P2X7-dependent functions in murine macrophages, European Journal of Immunology, vol.497, issue.5, pp.1473-85, 2010. ,
DOI : 10.1002/eji.200939741
Ectonucleotidases CD39 and CD73 on OvCA cells are potent adenosine-generating enzymes responsible for adenosine receptor 2A-dependent suppression of T cell function and NK cell cytotoxicity, Cancer Immunology, Immunotherapy, vol.249, issue.1???2, pp.1405-1423, 2011. ,
DOI : 10.1007/s00262-011-1040-4
Tumor-Associated Macrophages: From Mechanisms to Therapy, Immunity, vol.41, issue.1, pp.49-61, 2014. ,
DOI : 10.1016/j.immuni.2014.06.010
CD73 activity is dispensable for the polarization of M2 macrophages PMID:26258883, PLoS One, vol.10, 2015. ,
Interleukin-27: Balancing Protective and Pathological Immunity, Immunity, vol.37, issue.6, pp.960-969, 2012. ,
DOI : 10.1016/j.immuni.2012.11.003
The aryl hydrocarbon receptor interacts with c-Maf to promote the differentiation of type 1 regulatory T cells induced by IL-27, Nature Immunology, vol.181, issue.9, pp.854-61, 2010. ,
DOI : 10.1371/journal.pone.0009478
T cell-specific overexpression of interleukin-27 receptor ?? subunit (WSX-1) prevents spontaneous skin inflammation in MRL/lpr mice, British Journal of Dermatology, vol.131, issue.Suppl. 1, pp.1214-1234, 2011. ,
DOI : 10.1111/j.1365-2133.2011.10244.x
IL-12 and IL-27 regulate the phagolysosomal pathway in mycobacteria-infected human macrophages PMID:24618498, Cell Commun Signal, vol.12, issue.16, pp.1478-811, 2014. ,
IL-27 Activates Human Monocytes via STAT1 and Suppresses IL-10 Production but the Inflammatory Functions of IL-27 Are Abrogated by TLRs and p38, The Journal of Immunology, vol.180, issue.9, pp.6325-6358, 2008. ,
DOI : 10.4049/jimmunol.180.9.6325
Prognostic value of IL-27 polymorphisms and the susceptibility to epithelial ovarian cancer in a Chinese population, Immunogenetics, vol.28, issue.7, pp.85-92, 2014. ,
DOI : 10.1007/s00251-013-0753-2
Safety and Activity of Anti???PD-L1 Antibody in Patients with Advanced Cancer, New England Journal of Medicine, vol.366, issue.26, pp.2455-65, 2012. ,
DOI : 10.1056/NEJMoa1200694
Therapeutic PD-1 Pathway Blockade Augments with Other Modalities of Immunotherapy T-Cell Function to Prevent Immune Decline in Ovarian Cancer, Cancer Research, vol.73, issue.23, pp.6900-6912, 2013. ,
DOI : 10.1158/0008-5472.CAN-13-1550
PD-L1 on Tumor Cells Is Induced in Ascites and Promotes Peritoneal Dissemination of Ovarian Cancer through CTL Dysfunction, Clinical Cancer Research, vol.19, issue.6, pp.1363-74, 2013. ,
DOI : 10.1158/1078-0432.CCR-12-2199
Programmed death ligand-1 over-expression correlates with malignancy and contributes to immune regulation in ovarian cancer, Cancer Immunology, Immunotherapy, vol.73, issue.12, pp.215-239, 2014. ,
DOI : 10.1007/s00262-013-1503-x
High-pressure liquid chromatographic-fluorometric detection of adenosine and adenine nucleotides: Application to endogenous content and electrically induced release of adenyl purines in guinea pig vas deferens, Analytical Biochemistry, vol.137, issue.1, pp.93-1000003, 1984. ,
DOI : 10.1016/0003-2697(84)90352-X